BeOne Medicines Ltd. (ONC): Net Income
$286.93M
Year ended 2025-12-31
$655.71M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $286.93M | n/m | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | -$644.79M | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | -$881.71M | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$2.00B | n/m | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | -$1.46B | n/m | 2024-02-26, From 2021-01-01 |
| 2020-12-31 | -$1.62B | n/c | 2023-02-27, From 2020-01-01 |
| 2019-12-31 | -$948.63M | n/m | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | -$673.77M | n/m | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | -$93.11M | n/m | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | -$119.22M | n/m | 2019-02-28, From 2016-01-01 |
| 2015-12-31 | -$57.10M | n/m | 2018-02-28, From 2015-01-01 |
| 2014-12-31 | -$18.28M | n/a | 2017-03-22, From 2014-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| BeOne Medicines Ltd. (ONC) | 2025-12-31 | $286.93M | n/m |
| Elanco Animal Health Inc (ELAN) | 2025-12-31 | -$232.00M | n/m |
| Organon & Co. (OGN) | 2025-12-31 | $187.00M | -78.4% |
| Jazz Pharmaceuticals plc (JAZZ) | 2025-12-31 | -$356.15M | n/m |
| Perrigo Co PLC (PRGO) | 2025-12-31 | -$1.43B | n/m |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 2025-12-31 | $313.75M | n/m |
| BioMarin Pharmaceutical Inc (BMRN) | 2025-12-31 | $348.90M | -18.3% |
| United Therapeutics Corp (UTHR) | 2025-12-31 | $1.33B | +11.7% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $72.06M | n/m |
Compare ONC, ELAN, OGN, JAZZ side by side · Screen every company in Pharmaceutical Preparations ↗